Advancing Discussions Using a Video-based Support Tool About End-of-life Care (ADVISE)

March 25, 2025 updated by: Thaddeus J. Puzio, The University of Texas Health Science Center, Houston

Advancing Discussions Using a Video-based Support Tool About End-of-life Care: the ADVISE Project

The purpose of this study is to evaluate the effectiveness and implementation considerations of a video aid to improve communication and patient-centered outcomes in older injured adults

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

270

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • English or Spanish speaking
  • admitted to any level of care following trauma

Exclusion Criteria:

  • Prisoners
  • Existing do not resuscitate (DNR)/do not intubate (DNI)
  • Patients admitted while on hospice
  • Patients not expected to survive over 24-48 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual Care
Participants and/or surrogates will participate in discussions surrounding life-sustaining care at healthcare provider discretion.
Experimental: Video conversation aid
A video conversation aid which provides information regarding life-sustaining care and encourages further goals of care discussions with a healthcare provider will be shown to patients or their surrogates (for those incapacitated and unable to make their own decisions) on admission or within 48 hours whenever feasible

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants who had a transition in code status from full code
Time Frame: at time of discharge (about 5 days after admission)
Data will be reported categorically as number of participants who transitioned from full code to DNR/DNI, DNR, ok for intubation, or Comfort measures only
at time of discharge (about 5 days after admission)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of participants that recognize survival after Cardiopulmonary resuscitation (CPR) as less than 50 percent as assessed by a survey
Time Frame: at time of discharge (about 5 days after admission)
at time of discharge (about 5 days after admission)
Number of participants that received information about life-sustaining care outcomes as assessed by a survey
Time Frame: at time of discharge (about 5 days after admission)
at time of discharge (about 5 days after admission)
Number of participants that desire more information regarding life-sustaining care as assessed by a survey
Time Frame: at time of discharge (about 5 days after admission)
at time of discharge (about 5 days after admission)
Number of participants that had hospital-free days
Time Frame: in the first 30 days after admission
in the first 30 days after admission
Number of participants that had ICU-free days
Time Frame: at time of discharge (about 5 days after admission)
at time of discharge (about 5 days after admission)
Discharge disposition
Time Frame: at time of discharge (about 5 days after admission)
Data will be reported categorically as number of participants that were discharged to home, nursing facility, rehab facility, long term care hospital, hospice or number of participants that die
at time of discharge (about 5 days after admission)
Number of participants that had ventilator-free days
Time Frame: at time of discharge (about 5 days after admission)
at time of discharge (about 5 days after admission)
Decisional conflict score as assessed by the Decisional Conflict Scale
Time Frame: at time of discharge (about 5 days after admission)
This is a 4 item questionnaire, each is scored as 0(no) or 1(yes), for a maximum score of 4, higher score indicating no decisional conflict
at time of discharge (about 5 days after admission)
Number of interventional procedures
Time Frame: at time of discharge (about 5 days after admission)
Procedures include tracheostomy, feeding tube placement, dialysis initiation
at time of discharge (about 5 days after admission)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thaddeus J Puzio, MD, MS, FACS, The University of Texas Health Science Center, Houston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 17, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

January 28, 2025

First Submitted That Met QC Criteria

January 28, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 30, 2025

Last Update Submitted That Met QC Criteria

March 25, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HSC-MS-24-1256

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Injury

Clinical Trials on Video conversation aid

Subscribe